Connection
Susan Lana to Cyclophosphamide
This is a "connection" page, showing publications Susan Lana has written about Cyclophosphamide.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.002 |
|
|
|
-
Stroda KA, Murphy JD, Hansen RJ, Brownlee L, Atencio EA, Gustafson DL, Lana SE. Pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide in cats after oral, intravenous, and intraperitoneal administration of cyclophosphamide. Am J Vet Res. 2017 Jul; 78(7):862-866.
Score: 0.484
-
Warry E, Hansen RJ, Gustafson DL, Lana SE. Pharmacokinetics of cyclophosphamide after oral and intravenous administration to dogs with lymphoma. J Vet Intern Med. 2011 Jul-Aug; 25(4):903-8.
Score: 0.316
-
Wolf-Ringwall A, Lopez L, Elmslie R, Fowler B, Lori J, Sfiligoi G, Skope A, Arnold E, Hughes KL, Thamm DH, Ehrhart EJ, Avery AC, Lana SE. Prospective evaluation of flow cytometric characteristics, histopathologic diagnosis and clinical outcome in dogs with naïve B-cell lymphoma treated with a 19-week CHOP protocol. Vet Comp Oncol. 2020 Sep; 18(3):342-352.
Score: 0.143
-
Curran KM, Schaffer PA, Frank CB, Lana SE, Hamil LE, Burton JH, Labadie J, Ehrhart EJ, Avery PR. BCL2 and MYC are expressed at high levels in canine diffuse large B-cell lymphoma but are not predictive for outcome in dogs treated with CHOP chemotherapy. Vet Comp Oncol. 2017 Dec; 15(4):1269-1279.
Score: 0.028
-
Rebhun RB, Lana SE, Ehrhart EJ, Charles JB, Thamm DH. Comparative analysis of survivin expression in untreated and relapsed canine lymphoma. J Vet Intern Med. 2008 Jul-Aug; 22(4):989-95.
Score: 0.016
-
Walter CU, Biller BJ, Lana SE, Bachand AM, Dow SW. Effects of chemotherapy on immune responses in dogs with cancer. J Vet Intern Med. 2006 Mar-Apr; 20(2):342-7.
Score: 0.014
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|